Genetic marker, predictor of early relapse in pediatric ALL uncovered
Researchers recently discovered that by testing the level of NER (nucleotide excision repair) gene expression, pediatric oncologists can determine the likelihood of early relapse (less than three years) in their acute lymphoblastic leukemia (ALL) patients.
from Latest Science News -- ScienceDaily https://ift.tt/2EnLaiu
from Latest Science News -- ScienceDaily https://ift.tt/2EnLaiu
Comments
Post a Comment